CDRH Reopens Analyte-Specific Reagent Rule, Expanding IVD Oversight
This article was originally published in The Gray Sheet
Executive Summary
FDA will begin expanding oversight of homebrew in vitro diagnostics with a notice of proposed rulemaking on analyte-specific reagents in the coming weeks
You may also be interested in...
IVD Reps Propose Alternative 510(k) Route For In Vitro Analytical Tests
An IVD industry proposal to foster a new 510(k) mechanism for innovative analyte test kits would offer a timely alternative to "homebrew" diagnostic tests
IVD Reps Propose Alternative 510(k) Route For In Vitro Analytical Tests
An IVD industry proposal to foster a new 510(k) mechanism for innovative analyte test kits would offer a timely alternative to "homebrew" diagnostic tests
Warning Letters Needed To Rein In Outlier IVD Practices – Attorney Kahan
The Office of In Vitro Diagnostic Device Evaluation & Safety (OIVD) has a new program to deal with certain IVD problems on an "informal" basis, according to OIVD Director Steven Gutman